AbbVie Inc.'s Acquisition of Allergan PLC

An Analysis Group team led by Managing Principal Rebecca Kirk Fair and Vice President Emily Cotton was retained by Weil, Gotshal & Manges LLP on behalf of Allergan to provide competitive analyses in support of Allergan’s acquisition by AbbVie. The $63 billion deal, announced in June 2019, involved a mix of cash and stock. The acquisition was approved in August 2020 by both the European Union (EU) and the Federal Trade Commission (FTC).

Associated Experts & Consultants